+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Computer-Aided Drug Discovery Market By Type, By Therapeutic Area, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 180 Pages
  • June 2022
  • Region: Global
  • Allied Market Research
  • ID: 5671108
Description Jump to:
The global computer-aided drug discovery market was valued at $2,940.9 million in 2021 and is projected to reach $7,504.7 million by 2030, growing at a CAGR of 11.48% from 2022 to 2030.

The prevalence of chronic diseases, such as cardiovascular disease, has risen dramatically in recent years. According to the World Health Organization (WHO), the United Nations (UN) specialized agency responsible for international public health, the number of CVD patients may reach 23 million by the end of 2030. Furthermore, according to Premier, Inc., a notable healthcare improvement company, the demand for novel drugs for the treatment of CVD conditions has skyrocketed as a result of the COVID-19 crisis. The facts and figures presented above show that the need for the development of new drug molecules is expected to rise, which may have a positive impact on the global computer-aided drug discovery market during the analysis period.

However, lack of skilled labor for operating computer aided drug discovery solutions may hamper the global market growth. Also, lower product penetration in the emerging economies is also restraining the global computer-aided drug discovery market.

Emerging concepts such as artificial intelligence (AI) and big data in computer-aided drug discovery, on the other hand, may drive the market over the forecast period. Many aspects of drug discovery can benefit from artificial intelligence, including drug design, chemical synthesis, drug screening, drug repurposing, and polypharmacology.

The global computer-aided drug discovery market is segmented on the basis of type, therapeutic area, end-user, and region. By type, the market is classified into structure-based drug design (SBDD), ligand-based drug design (LBDD), and sequence-based approaches. By therapeutic area, the analysis has been divided into oncology, neurology, cardiovascular disease, respiratory disease, diabetes, and others. By end-user, the market has been divided into pharmaceutical companies, biotechnology companies and research laboratories. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in this report include BOCSCI Inc., Bioduro-Sundia, Schrödinger, Inc., Aragen Life Sciences Pvt. Ltd., Aris Pharmaceuticals, Inc, Charles River Laboratories, Bayer AG, AstraZeneca, and Albany Molecular Research Inc. (AMRI).

Key Market Segments

By Type

  • Structure Based Drug Design
  • Ligand-Based Drug Design
  • Sequence-Based Approaches

By Therapeutic Area

  • Oncology
  • Neurology
  • Cardiovascular Disease
  • Respiratory Disease
  • Diabetes
  • Others

By End User

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Research Laboratories

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest Of Asia Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of LAMEA

Key Market Players

  • charles river laboratories
  • BOC Sciences
  • Bioduro-Sundia
  • Schrödinger, Inc.
  • Aragen Life Sciences Pvt. Ltd.
  • Aris Pharmaceuticals, Inc.
  • Bayer AG
  • AstraZeneca plc
  • Albany Molecular Research Inc. (AMRI)

 

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Regulatory Guidelines
3.8.Value Chain Analysis
3.9.Market Share Analysis
3.10.Key Regulation Analysis
3.11.Patent Landscape
CHAPTER 4: COMPUTER-AIDED DRUG DISCOVERY MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Structure Based Drug Design
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Ligand-Based Drug Design
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Sequence-Based Approaches
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: COMPUTER-AIDED DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA
5.1 Overview
5.1.1 Market size and forecast
5.2 Oncology
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Neurology
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Cardiovascular Disease
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
5.5 Respiratory Disease
5.5.1 Key market trends, growth factors and opportunities
5.5.2 Market size and forecast, by region
5.5.3 Market analysis by country
5.6 Diabetes
5.6.1 Key market trends, growth factors and opportunities
5.6.2 Market size and forecast, by region
5.6.3 Market analysis by country
5.7 Others
5.7.1 Key market trends, growth factors and opportunities
5.7.2 Market size and forecast, by region
5.7.3 Market analysis by country
CHAPTER 6: COMPUTER-AIDED DRUG DISCOVERY MARKET, BY END USER
6.1 Overview
6.1.1 Market size and forecast
6.2 Pharmaceutical Companies
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Biotechnology Companies
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Research Laboratories
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: COMPUTER-AIDED DRUG DISCOVERY MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Therapeutic Area
7.2.4 North America Market size and forecast, by End User
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Therapeutic Area
7.2.5.1.3 Market size and forecast, by End User
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Therapeutic Area
7.2.5.2.3 Market size and forecast, by End User
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Therapeutic Area
7.2.5.3.3 Market size and forecast, by End User
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Therapeutic Area
7.3.4 Europe Market size and forecast, by End User
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Therapeutic Area
7.3.5.1.3 Market size and forecast, by End User
7.3.5.2 United Kingdom
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Therapeutic Area
7.3.5.2.3 Market size and forecast, by End User
7.3.5.3 France
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Therapeutic Area
7.3.5.3.3 Market size and forecast, by End User
7.3.5.4 Spain
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Therapeutic Area
7.3.5.4.3 Market size and forecast, by End User
7.3.5.5 Italy
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Therapeutic Area
7.3.5.5.3 Market size and forecast, by End User
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Therapeutic Area
7.3.5.6.3 Market size and forecast, by End User
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Therapeutic Area
7.4.4 Asia-Pacific Market size and forecast, by End User
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Therapeutic Area
7.4.5.1.3 Market size and forecast, by End User
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Therapeutic Area
7.4.5.2.3 Market size and forecast, by End User
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Therapeutic Area
7.4.5.3.3 Market size and forecast, by End User
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Therapeutic Area
7.4.5.4.3 Market size and forecast, by End User
7.4.5.5 Australia
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Therapeutic Area
7.4.5.5.3 Market size and forecast, by End User
7.4.5.6 Rest Of Asia Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Therapeutic Area
7.4.5.6.3 Market size and forecast, by End User
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Therapeutic Area
7.5.4 LAMEA Market size and forecast, by End User
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Therapeutic Area
7.5.5.1.3 Market size and forecast, by End User
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Therapeutic Area
7.5.5.2.3 Market size and forecast, by End User
7.5.5.3 UAE
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Therapeutic Area
7.5.5.3.3 Market size and forecast, by End User
7.5.5.4 South Africa
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Therapeutic Area
7.5.5.4.3 Market size and forecast, by End User
7.5.5.5 Rest of LAMEA
7.5.5.5.1 Market size and forecast, by Type
7.5.5.5.2 Market size and forecast, by Therapeutic Area
7.5.5.5.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 charles river laboratories
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 BOC Sciences
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Bioduro-Sundia
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 Schrödinger, Inc.
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 Aragen Life Sciences Pvt. Ltd.
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Aris Pharmaceuticals, Inc.
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Bayer AG
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 AstraZeneca plc
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Albany Molecular Research Inc. (AMRI)
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
List of Tables
Table 1. Global Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 2. Beard Transplant Market Revenue, for Follicular Unit Extraction, by Region , 2021-2031,($Million)
Table 3. Beard Transplant Market for Follicular Unit Extraction by Country, 2021-2031,($Million)
Table 4. Beard Transplant Market Revenue, for Follicular Unit Transplantation, by Region , 2021-2031,($Million)
Table 5. Beard Transplant Market for Follicular Unit Transplantation by Country, 2021-2031,($Million)
Table 6. Beard Transplant Market Revenue, for Others, by Region , 2021-2031,($Million)
Table 7. Beard Transplant Market for Others by Country, 2021-2031,($Million)
Table 8. Global Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 9. Beard Transplant Market Revenue, for Masculine, by Region , 2021-2031,($Million)
Table 10. Beard Transplant Market for Masculine by Country, 2021-2031,($Million)
Table 11. Beard Transplant Market Revenue, for Transmasculine, by Region , 2021-2031,($Million)
Table 12. Beard Transplant Market for Transmasculine by Country, 2021-2031,($Million)
Table 13. Global Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 14. Beard Transplant Market Revenue, for Hospitals, by Region , 2021-2031,($Million)
Table 15. Beard Transplant Market for Hospitals by Country, 2021-2031,($Million)
Table 16. Beard Transplant Market Revenue, for Clinics, by Region , 2021-2031,($Million)
Table 17. Beard Transplant Market for Clinics by Country, 2021-2031,($Million)
Table 18. Beard Transplant Market Revenue, for Surgery Centers, by Region , 2021-2031,($Million)
Table 19. Beard Transplant Market for Surgery Centers by Country, 2021-2031,($Million)
Table 20. Beard Transplant Market, by Region, 2021-2031,($Million)
Table 21. North America Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 22. North America Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 23. North America Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 24. North America Beard Transplant Market, by Country, 2021-2031,($Million)
Table 25. U.S. Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 26. U.S. Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 27. U.S. Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 28. Canada Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 29. Canada Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 30. Canada Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 31. Mexico Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 32. Mexico Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 33. Mexico Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 34. Europe Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 35. Europe Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 36. Europe Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 37. Europe Beard Transplant Market, by Country, 2021-2031,($Million)
Table 38. Germany Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 39. Germany Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 40. Germany Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 41. U.K. Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 42. U.K. Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 43. U.K. Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 44. France Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 45. France Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 46. France Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 47. Italy Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 48. Italy Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 49. Italy Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 50. Spain Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 51. Spain Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 52. Spain Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 53. Rest of Europe Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 54. Rest of Europe Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 55. Rest of Europe Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 56. Asia-Pacific Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 57. Asia-Pacific Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 58. Asia-Pacific Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 59. Asia-Pacific Beard Transplant Market, by Country, 2021-2031,($Million)
Table 60. China Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 61. China Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 62. China Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 63. Japan Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 64. Japan Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 65. Japan Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 66. India Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 67. India Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 68. India Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 69. Singapore Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 70. Singapore Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 71. Singapore Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 72. Australia Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 73. Australia Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 74. Australia Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 75. Rest of Asia-Pacific Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 76. Rest of Asia-Pacific Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 77. Rest of Asia-Pacific Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 78. LAMEA Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 79. LAMEA Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 80. LAMEA Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 81. LAMEA Beard Transplant Market, by Country, 2021-2031,($Million)
Table 82. Brazil Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 83. Brazil Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 84. Brazil Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 85. Argentina Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 86. Argentina Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 87. Argentina Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 88. Saudi Arabia Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 89. Saudi Arabia Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 90. Saudi Arabia Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 91. South Africa Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 92. South Africa Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 93. South Africa Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 94. Rest of LAMEA Beard Transplant Market, by Approach, 2021-2031,($Million)
Table 95. Rest of LAMEA Beard Transplant Market, by End-user, 2021-2031,($Million)
Table 96. Rest of LAMEA Beard Transplant Market, by Service Provider, 2021-2031,($Million)
Table 97. Ashlin Alexander Facial Cosmetic Surgery: Company Snapshot
Table 98. Ashlin Alexander Facial Cosmetic Surgery: Operating Segments
Table 99. Ashlin Alexander Facial Cosmetic Surgery: Product Portfolio
Table 100. Ashlin Alexander Facial Cosmetic Surgery: Net Sales
Table 101. Ashlin Alexander Facial Cosmetic Surgery: Key Stratergies
Table 102. Bain Clinic: Company Snapshot
Table 103. Bain Clinic: Operating Segments
Table 104. Bain Clinic: Product Portfolio
Table 105. Bain Clinic: Net Sales
Table 106. Bain Clinic: Key Stratergies
Table 107. Bosley: Company Snapshot
Table 108. Bosley: Operating Segments
Table 109. Bosley: Product Portfolio
Table 110. Bosley: Net Sales
Table 111. Bosley: Key Stratergies
Table 112. Capilclinic: Company Snapshot
Table 113. Capilclinic: Operating Segments
Table 114. Capilclinic: Product Portfolio
Table 115. Capilclinic: Net Sales
Table 116. Capilclinic: Key Stratergies
Table 117. Dezire Clinic: Company Snapshot
Table 118. Dezire Clinic: Operating Segments
Table 119. Dezire Clinic: Product Portfolio
Table 120. Dezire Clinic: Net Sales
Table 121. Dezire Clinic: Key Stratergies
Table 122. Dhi Global Medical Group: Company Snapshot
Table 123. Dhi Global Medical Group: Operating Segments
Table 124. Dhi Global Medical Group: Product Portfolio
Table 125. Dhi Global Medical Group: Net Sales
Table 126. Dhi Global Medical Group: Key Stratergies
Table 127. Igraft Global Hair Services Pvt Ltd: Company Snapshot
Table 128. Igraft Global Hair Services Pvt Ltd: Operating Segments
Table 129. Igraft Global Hair Services Pvt Ltd: Product Portfolio
Table 130. Igraft Global Hair Services Pvt Ltd: Net Sales
Table 131. Igraft Global Hair Services Pvt Ltd: Key Stratergies
Table 132. Maxim Hair Restoration: Company Snapshot
Table 133. Maxim Hair Restoration: Operating Segments
Table 134. Maxim Hair Restoration: Product Portfolio
Table 135. Maxim Hair Restoration: Net Sales
Table 136. Maxim Hair Restoration: Key Stratergies
Table 137. Smile Hair Clinic: Company Snapshot
Table 138. Smile Hair Clinic: Operating Segments
Table 139. Smile Hair Clinic: Product Portfolio
Table 140. Smile Hair Clinic: Net Sales
Table 141. Smile Hair Clinic: Key Stratergies
Table 142. Wimpole Clinic: Company Snapshot
Table 143. Wimpole Clinic: Operating Segments
Table 144. Wimpole Clinic: Product Portfolio
Table 145. Wimpole Clinic: Net Sales
Table 146. Wimpole Clinic: Key Stratergies
List of Figures
Figure 1. Computer-Aided Drug Discovery Market Segmentation
Figure 2. Computer-Aided Drug Discovery Market,2021-2030
Figure 3. Computer-Aided Drug Discovery Market,2021-2030
Figure 4. Top Investment Pockets, by Region
Figure 5. Porter Five-1
Figure 6. Porter Five-2
Figure 7. Porter Five-3
Figure 8. Porter Five-4
Figure 9. Porter Five-5
Figure 10. Top Player Positioning
Figure 11. Computer-Aided Drug Discovery Market:Drivers, Restraints and Opportunities
Figure 12. Regulatory Guidelines
Figure 13. Value Chain Analysis
Figure 14. Market Share Analysis
Figure 15. Key Regulation Analysis
Figure 16. Patent Analysis by Company
Figure 17. Patent Analysis by Country
Figure 18. Computer-Aided Drug Discovery Market,By Type,2021(%)
Figure 19. Comparative Share Analysis of Structure Based Drug Design Computer-Aided Drug Discovery Market,2021-2030(%)
Figure 20. Comparative Share Analysis of Ligand-based Drug Design Computer-Aided Drug Discovery Market,2021-2030(%)
Figure 21. Comparative Share Analysis of Sequence-based Approaches Computer-Aided Drug Discovery Market,2021-2030(%)
Figure 22. Computer-Aided Drug Discovery Market,By Therapeutic Area,2021(%)
Figure 23. Comparative Share Analysis of Oncology Computer-Aided Drug Discovery Market,2021-2030(%)
Figure 24. Comparative Share Analysis of Neurology Computer-Aided Drug Discovery Market,2021-2030(%)
Figure 25. Comparative Share Analysis of Cardiovascular Disease Computer-Aided Drug Discovery Market,2021-2030(%)
Figure 26. Comparative Share Analysis of Respiratory Disease Computer-Aided Drug Discovery Market,2021-2030(%)
Figure 27. Comparative Share Analysis of Diabetes Computer-Aided Drug Discovery Market,2021-2030(%)
Figure 28. Comparative Share Analysis of Others Computer-Aided Drug Discovery Market,2021-2030(%)
Figure 29. Computer-Aided Drug Discovery Market,By End-user,2021(%)
Figure 30. Comparative Share Analysis of Pharmaceutical Companies Computer-Aided Drug Discovery Market,2021-2030(%)
Figure 31. Comparative Share Analysis of Biotechnology Companies Computer-Aided Drug Discovery Market,2021-2030(%)
Figure 32. Comparative Share Analysis of Research Laboratories Computer-Aided Drug Discovery Market,2021-2030(%)
Figure 33. Computer-Aided Drug Discovery Market by Region,2021
Figure 34. U.S. Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 35. Canada Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 36. Mexico Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 37. Germany Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 38. United Kingdom Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 39. France Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 40. Spain Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 41. Italy Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 42. Rest of Europe Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 43. China Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 44. Japan Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 45. India Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 46. South Korea Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 47. Australia Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 48. Rest of Asia-Pacific Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 49. Brazil Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 50. Saudi Arabia Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 51. Uae Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 52. South Africa Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 53. Rest of LAMEA Computer-Aided Drug Discovery Market,2021-2030($Million)
Figure 54. Top Winning Strategies, by Year
Figure 55. Top Winning Strategies, by Development
Figure 56. Top Winning Strategies, by Company
Figure 57. Product Mapping of Top 10 Players
Figure 58. Competitive Dashboard
Figure 59. Competitive Heatmap of Top 10 Key Players
Figure 60. Charles River Laboratories.: Net Sales ,($Million)
Figure 61. Boc Sciences.: Net Sales ,($Million)
Figure 62. Bioduro-Sundia.: Net Sales ,($Million)
Figure 63. Schrödinger, Inc..: Net Sales ,($Million)
Figure 64. Aragen Life Sciences Pvt. Ltd..: Net Sales ,($Million)
Figure 65. Aris Pharmaceuticals, Inc..: Net Sales ,($Million)
Figure 66. Bayer AG.: Net Sales ,($Million)
Figure 67. Astrazeneca PLC.: Net Sales ,($Million)
Figure 68. Albany Molecular Research Inc. (Amri).: Net Sales ,($Million)

Executive Summary

According to the report, titled, “Computer-Aided Drug Discovery Market," the computer-aided drug discovery market size was $2.9 billion in 2021, and is estimated to reach $7.5 billion by 2030, growing at a CAGR of 11.48% from 2022 to 2030.

In the world of drug development, CADD is an effective tool for identifying potential therapeutic compounds. Computer-aided Drug Design (CADD) is a drug design technique used in medicinal chemistry. The method use software to create several chemical structures with minor modifications to a single medication structure that has already been shown to be therapeutically efficacious. CADD's main goal is to screen, optimise, and analyse the compound's activity against the target. It is a multidisciplinary method that is used by both academic institutions and commercial pharmaceutical firms to improve efficacy while minimising or eliminating negative effects. It is now the best option for elevated screening, which is widely used in drug development.

Growing research and development activities in the field of drugs and vaccines is likely to accelerate computer aided drug discovery market share growth. CADD techniques/tools have been used in almost every stage of the drug development pipeline because of their ability to accelerate hit identification, strike to lead, and result enhancement. Over the last two decades, advances in computer-aided drug design at the technique/tool level, combined with the development of computational power, have enabled the scientific community to begin producing disease-oriented fast and reliable remedies at a low cost and in a manageable time frame.

Computer aided drug discovery market size is likely to accelerate in the coming few years owing to incorporation of advanced technology in CADD. The merging of Artificial Intelligence and Machine Learning with structure-based approaches has emerged as a powerful new tool for drug development. Perhaps the scientific community will have to overcome the challenges posed by algorithms, scoring systems, and the lack of available data. This basic platform helps to speed up clinical trials and reduce the failure rate of promising medication candidates. SBDD has the potential to become a unique, dependable, and efficient drug design technique in the future.

The global computer-aided drug discovery market is segmented on the basis of type, therapeutic area, end-user, and region. By type, the market is classified into structure-based drug design (SBDD), ligand-based drug design (LBDD), and sequence-based approaches. By therapeutic area, the analysis has been divided into oncology, neurology, cardiovascular disease, respiratory disease, diabetes, and others. By end-user, the market has been divided into pharmaceutical companies, biotechnology companies, and research laboratories. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players profiled in this report include BOCSCI Inc., Bioduro-Sundia, Schrödinger, Inc., Aragen Life Sciences Pvt. Ltd., Aris Pharmaceuticals, Inc, Charles River Laboratories, Bayer AG, AstraZeneca, and Albany Molecular Research Inc. (AMRI).

The report focuses on the global computer-aided drug discovery market trends and the major products & applications, where computer-aided drug discovery is deployed. It further highlights numerous factors that influence the global computer-aided drug discovery market growth, such as forecast, trends, drivers, restraints, opportunities, and roles of different key players that shape the market. The report focuses on Computer-aided drug discovery market analysis, computer-aided drug discovery market share, and computer-aided drug discovery market opportunities in various countries, presenting data in terms of value. The revenue is calculated by proliferating the volume by region-specific prices, considering the region-wise differentiated prices.

IMPACT OF COVID-19 ON THE GLOBAL COMPUTER-AIDED DRUG DISCOVERY MARKET

  • The pandemic has had a negative impact on almost every industry segment in various ways, including supply chain disruptions and product delays. The global computer-aided drug discovery (CADD) market, on the other hand, has seen a positive impact throughout the COVID-19 pandemic.
  • Computational technologies, specifically computer-aided virtual screening and molecular modelling, can play an important role in understanding the structural aspects of multiple coronavirus molecular targets and identifying novel lead molecules. In addition, research institutes and pharmaceutical and biotechnology firms are stepping up their efforts to combat a global pandemic. For example, in May 2021, researchers at Stony Brook University's Laufer Center, a hub for research in Physical and Quantitative Biology, announced to use computing therapeutics to discover chemicals that activate or inhibit viral molecules. This research is expected to accelerate drug discovery industry for coronavirus treatment.

Key Findings of the Study

  • On the basis of type, the structure-based drug design segment emerged as the global leader in 2021 and is anticipated to be the largest market during the forecast period.
  • On the basis of therapeutic area, the oncology segment emerged as the global leader in 2021 and is anticipated to be the largest market during the forecast period.
  • On the basis of end user, the pharmaceutical companies segment emerged as the global leader in 2021 and is anticipated to be the largest market during the forecast period.
  • On the basis of region, Asia-Pacific is projected to have the fastest growing market during the forecast period.

Companies Mentioned

  • Charles River Laboratories
  • Boc Sciences
  • Bioduro-Sundia
  • Schrödinger, Inc.
  • Aragen Life Sciences Pvt. Ltd.
  • Aris Pharmaceuticals, Inc.
  • Bayer AG
  • Astrazeneca plc
  • Albany Molecular Research Inc. (Amri)

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages180
PublishedJune 2022
Forecast Period2021 - 2030
Estimated Market Value ( USD ) in 2021 $ 2940.9 million
Forecasted Market Value ( USD ) by 2030 $ 7504.7 million
Compound Annual Growth Rate11.0%
Regions CoveredGlobal
No. of Companies Mentioned9

Related Topics

Related Reports

Computer-aided Drug Discovery Market by Type, Therapeutic Area, End User - Global Forecast 2025-2030 - Product Image

Computer-aided Drug Discovery Market by Type, Therapeutic Area, End User - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Computer-Aided Drug Discovery - Global Strategic Business Report - Product Image

Computer-Aided Drug Discovery - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
2024 Computer-Aided Drug Discovery Market Forecast (2025-2030 Outlook) - Market Opportunities Report - Product Image

2024 Computer-Aided Drug Discovery Market Forecast (2025-2030 Outlook) - Market Opportunities Report

  • Report
  • 70 Pages
  • Global
From
Therapeutic Drug Monitoring Global Market Report 2024 - Product Image

Therapeutic Drug Monitoring Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Computer-Aided Drug Discovery Methods: A Brief Introduction - Product Image

Computer-Aided Drug Discovery Methods: A Brief Introduction

  • Book
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.